Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dichotic Listening in Depression
NCT00296725Phase 2Completed
- Sponsor
- New York State Psychiatric Institute
- Start
- Apr 1994
- Primary completion
- Jun 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fluoxetine, imipramine in major depressive disorder (MDD), persistent depressive disorder (PDD), depressive disorder not otherwise specified (DD-NOS), sponsored by New York State Psychiatric Institute. Started Apr 1994; status: completed.
02
Drugs
fluoxetineimipramine
03
Conditions
major depressive disorder (MDD)persistent depressive disorder (PDD)depressive disorder not otherwise specified (DD-NOS)
Beyond the preview
Go deeper on NCT00296725.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00296725.